Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilitiesCarl M. Gay, Lauren A. Byers, C. Allison Stewart et al.|Cancer Cell|2021Cited by 930
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLCMarcelo V. Negrão, Sandip Pravin Patel, Michael J. Dennis et al.|Cancer Discovery|2023Cited by 181
Improved immune function of Chinese soft-shelled turtles (Pelodiscus sinensis) through oral probiotics via the TLR signaling pathwayShujie Xu, Weifen Li, Qi Wang et al.|Aquaculture|2022Cited by 18
Sustained Aurora Kinase B Expression Confers Resistance to PI3K Inhibition in Head and Neck Squamous Cell CarcinomaPooja A. Shah, Faye M. Johnson, Vaishnavi Sambandam et al.|Cancer Research|2022Cited by 11
Data from Sustained Aurora Kinase B Expression Confers Resistance to PI3K Inhibition in Head and Neck Squamous Cell CarcinomaPooja A. Shah, Faye M. Johnson, Vaishnavi Sambandam et al.|Unknown|2023Cited by 0